Asthma Therapeutics Market Report, Industry Analysis, Share, Size and Forecast Till 2025

Global Asthma Therapeutics Market Research Report and Forecast 2025

www.imarcgroup.com

Sales@imarcgroup.com

+1-631-791-1145

About IMARC

WHO WE ARE? • We are a leading market research firm with expertise in market intelligence and business research • We deliver high quality, well-knitted, meaningful studies • We excel at understanding and synergizing with the business priorities of our partners and delivering tailored solutions

WHAT DO WE DO? • Market research and business insights • Competitive intelligence and benchmarking • Strategy consulting • Consumer surveys and feedback analysis

WHAT DO WE COVER? • Food And beverages • Dairy and dairy products • Agriculture and farming • Chemicals and materials • FMCG • Paper and packaging

• Social and rural research

• Healthcare

• Market entry strategy

• Machinery, electronics and semiconductors

• Syndicated Reports

WHO DO WE SERVE? • Collaborating with fortune 500 companies and SMEs • Serving all major clients from different industry which include Chemical & Materials, Food & Beverages, Packaging, Healthcare, Automotive, Heavy Industries, Retail, etc.

WhatWe Do

Competitive Intelligence and Benchmarking At IMARC, we help customers determine a competitor’s brand image and perception in the marketplace as compared to other key players.

Cost Modeling and Cost Forecasting A good cost model supports organizations during negotiations to build strong relationships with suppliers. Cost modelling and price forecasting services from IMARC ensure clients make informed decisions.

Market Research & Business Insights To develop deep customer understanding, we employ a range of quantitative and qualitative marketing research approaches along with big data techniques that are both innovative and pragmatic

Country Entry Strategy IMARC team drafts and implement an optimum country entry strategy for expanding business in the country. Our team of consultants deeply evaluates and strategize the market opportunities for our clients and accentuate the business in congruence with Government regulations, exports and imports scenario, demand supply gap analysis and many more.

Consumer Survey & Feedback Reports Consumer profiling, survey with end consumers, collection of their feedback and deep analysis. Based on the analysis, strategic decisions to enter in a new region, launch of new product, improvising the existing services

Competitive Intelligence and Benchmarking

Market Research & Business Insights

Consumer Survey & Feedback Reports

Country Entry Strategy

Cost Modeling and Cost Forecasting

REPORT OBJECTIVES & Highlight

Report Description According to IMARC Group’s latest report, titled “Asthma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global asthma therapeutics market grew at a CAGR of around 4% during 2014-2019. Looking forward, IMARC Group expects the global market to continue its moderate growth during the next five years.

Asthma therapeutics include a group of pharmaceutical drugs that are primarily used for treating asthma. The drugs help in mitigating the symptoms of the respiratory disease, which usually gets triggered by exposure to various outdoor and indoor causative agents, including dust, allergens, pollutants, etc. Asthma therapeutics generally include bronchodilators and antiinflammatory drugs, such as long-acting beta-agonists (LABA), methylxanthine, immunomodulators, corticosteroids, leukotriene modifiers, etc. These drugs aid in expansion of air passage into the lungs, which further enables the proper movement of air to enhance the breathing process. Asthma therapeutics drugs are usually administered via inhalers or nebulizers and are adopted in quick-relief medications and long-term asthma control therapies.

The rising prevalence of asthma due to the growing air pollution levels is currently propelling the adoption of asthma therapeutics. Additionally, the increasing consumer awareness towards the easy availability of effective asthma therapeutics is also catalyzing the market growth. Furthermore, the emergence of combination therapies for treating respiratory diseases, such as asthma, is driving the demand for asthma therapeutics. Numerous pharma companies are constantly focusing on clinical trials of pipeline asthma drugs with higher efficacy and prolonged effect. Several other factors, including the growing healthcare expenditures, continuous upgradation of healthcare infrastructures, extensive R&D activities in the medical sector, etc., are expected to further bolster the global asthma therapeutics market in the coming years.

Get a PDF sample of this report for more detailed market insights: https://www.imarcgroup.com/asthma-therapeutics-market/requestsample

Report Description Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global asthma therapeutics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market on the basis of region, drugs class, product type, treatment type and route of administration.

Breakup by Drug Class: 

Anti-Inflammatory Drugs



Bronchodilators



Combination Therapies

Breakup by Product Type: 

Inhalers o Dry Powder Inhalers o Metered Dose Inhalers o Soft Mist Inhalers

Report Description 

Nebulizers o Pneumatic Nebulizers o Ultrasonic Nebulizers o Mesh Nebulizers

Breakup by Treatment Type: 

Quick-Relief Medications



Long-Term Asthma Control Medications

Breakup by Route of Administration: 

Inhalation



Oral



Parenteral

Report Description Breakup by Region:  North America o United States o Canada  Asia Pacific o China o Japan o India o South Korea o Australia o Indonesia o Others  Europe o Germany o France o United Kingdom o Italy o Spain o Russia o Others  Latin America o Brazil o Mexico o Others Middle East and Africa

Report Description Explore full report with table of contents: https://www.imarcgroup.com/asthma-therapeutics-market Competitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca, Abbott, Amgen Inc., Biogen Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Merck & Co. Inc., Novartis AG, Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.) and Teva Pharmaceutical Industries Ltd. Browse Related Reports: https://www.imarcgroup.com/bronopol-market https://www.imarcgroup.com/lactose-powder-market About Us IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise

Report Description Contact US: IMARC Group 30 N Gould St, Ste R Sheridan, WY 82801, USA Website: https://www.imarcgroup.com/ Email: sales@imarcgroup.com USA: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800 Follow us on twitter: @imarcglobal Linkedin: https://www.linkedin.com/company/imarc-group Note: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want to need latest primary and secondary data (2020-2025) with Cost Module, Business Strategy, Distribution Channel, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Table of Contents

Table of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Asthma Therapeutics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Drug Class 6.1 Anti-Inflammatory Drugs 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Bronchodilators 6.2.1 Market Trends 6.2.2 Market Forecast

Table of Contents 6.3 Combination Therapies 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Product Type 7.1 Inhalers 7.1.1 Market Trends 7.1.2 Major Types 7.1.2.1 Dry Powder Inhalers 7.1.2.2 Metered Dose Inhalers 7.1.2.3 Soft Mist Inhalers 7.1.3 Market Forecast 7.2 Nebulizers 7.2.1 Market Trends 7.2.2 Major Types 7.2.2.1 Pneumatic Nebulizers 7.2.2.2 Ultrasonic Nebulizers 7.2.2.3 Mesh Nebulizers 7.2.3 Market Forecast 8 Market Breakup by Treatment Type 8.1 Quick-Relief Medications 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Long-Term Asthma Control Medications 8.2.1 Market Trends 8.2.2 Market Forecast 9 Market Breakup by Route of Administration 9.1 Inhalation 9.1.1 Market Trends 9.1.2 Market Forecast

Table of Contents 9.2 Oral 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Parenteral 9.3.1 Market Trends 9.3.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends

Table of Contents 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Others 10.2.7.1 Market Trends 10.2.7.2 Market Forecast 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast

Table of Contents 10.4 Latin America 10.4.1 Brazil 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Price Analysis

Table of Contents 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 AstraZeneca 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 Abbott 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio 15.3.2.3 Financials 15.3.2.4 SWOT Analysis 15.3.3 Amgen Inc. 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.3.3 Financials 15.3.3.4 SWOT Analysis 15.3.4 Biogen Inc. 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.4.3 Financials 15.3.4.4 SWOT Analysis 15.3.5 Boehringer Ingelheim GmbH 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.6 F. Hoffmann-La Roche AG 15.3.6.1 Company Overview

Table of Contents

15.3.6.2 Product Portfolio 15.3.6.3 SWOT Analysis 15.3.7 GlaxoSmithKline Plc. 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.7.3 Financials 15.3.7.4 SWOT Analysis 15.3.8 Merck & Co. Inc. 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.8.3 Financials 15.3.8.4 SWOT Analysis 15.3.9 Novartis AG 15.3.9.1 Company Overview 15.3.9.2 Product Portfolio 15.3.9.3 Financials 15.3.9.4 SWOT Analysis 15.3.10 Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.) 15.3.10.1 Company Overview 15.3.10.2 Product Portfolio 15.3.10.3 SWOT Analysis 15.3.11 Teva Pharmaceutical Industries Ltd. 15.3.11.1 Company Overview 15.3.11.2 Product Portfolio 15.3.11.3 Financials 15.3.11.4 SWOT Analysis

Report FAQs Team Team Profile Profile

Team Profile

Engineers and Post Graduates Account for 75% of our Team

Growing team of 150+ employees with deep market knowledge

Over 1000 Independent Consultants from different sectors

Post Graduates; 30.00%

Engineers; 45.00%

Non Engineering Graduates; 15.00% Others; 10.00%

Talents from some of the top universities

modelling specialists with unmatched expertise in quantitative research Individuals with experience in specific industries and having sound knowledge of targeted functional areas Commercial and non-commercial relationships with some of the top research institutes

Report FAQs Words From Client

Words From Client

“We have been working with IMARC Group for over two years now. I must say that the word impossible doesn’t seems to appear in their dictionary,. These guys can provide data for any market in any country. I have been given them challenging assignments to work upon and have been quite impressed with their approach and results.”

-Global Procurement Technology Manager – Global FMCG Giant “IMARC Group has great domain expertise and knowledge base provided all the inputs necessary for us to define the path forward and launch our diagnostic successfully in the market where other players were always afraid before investing.”

-Vice President Marketing – European Diagnostic Company

“We were really impressed with their research findings on the South India dairy market. The innovative idea suggested by them have given us altogether different aspect to look at the problem. We started with them on small project but now thinking on doing more strategic project with them.”

-National Manager (Marketing) – Indian Diary Giant “IMARC Group helped us with the outsourcing of a major part of clinical trials to India. In the beginning we were skeptic of this idea. But the success achieved from this strategy is driving us to outsource other verticals of our business to low cost destinations” - Member of Board of Managing Director – Global Pharmaceutical Giant “Working with IMARC Group has been a great experience. They were able to provide us with a comprehensive business report on the India wastewater treatment market. The finding from the reports are played a major role in our business strategies and future decision making” -Senior Vice President – Major Indian Effluent Treatment Company

Report FAQs

Report FAQs

Report FAQs

01 02 03 04 05

Do you provide market share information for a specific country/segment?

Yes, we provide market share information and insights considering the scope. This service is provided as a part of customization requirements.

My research requirement is very specific; can I customized the report?

Yes, we provide customization of reports based on your requirements. It will be charged based on the scope of customization. Client have free access to pre-sales analyst briefs to discuss requirement and recommendations.

How do you arrive at the market numbers?

Our research methodology is a three cyclic process. It starts from information procurement from our inhouse database, primary research and secondary sources. The second step is data collection and analysis.

The third step is data validation from industry experts, key players and other stakeholders.

I have a pre-defined budget. Can I buy chapters/sections of the report?

We generally do not promote the sale of separate or individual segments from within a study, as it might fail to relay the actual meaning of the study or provide a holistic picture of the market. However, in special cases, select chapters are provided based on the client requirement.

Do you offer post sales support?

Yes, we offer post purchase analyst support for 4-6 weeks to our client in case they have any query within the scope of study.

Report FAQs

06 07 08 09

Who are your client?

We have engaged 550+ clients across the globe. More than half of our client are re-engage us for additional reports and services

How will I receive the report?

The report in a PDF and Excel format will be sent to you electronically at your registered email address.

Moreover, PPT and Word formats are also delivered to clients, on special requests.

How often does IMARC update studies?

Research studies or reports are updated once in 6 months or a year depending on the traction & need. Please contact our sales team to inquire about a report update status.

Will I have to pay for the post-sale customization needs?

We offer our clients with a free 10% customization on the syndicated report. In case you have not availed this service as a pre-sale facility, we request you to share the requirements with our sales team. The research team post a feasibility will share the purview of the post-sale customization along with the price (if applicable) and the timeline.

SOME OF OUR KEY CUSTOMERS